CSE suspends trading in iDNA Genomics bonds over missing trustee

Nicosia, Cyprus. The Cyprus Stock Exchange (CSE) has halted trading in bonds issued by iDNA Genomics Public Ltd for as long as two months. The move follows the company’s failure to name a new trustee after its earlier representative stepped down.

Legal basis and timing

The CSE announced that the suspension began on Monday, November 2, 2026, and was ordered under Article 183 of the Cyprus Securities and Stock Exchange Law.

Related: iDNA Genomics bond trustee resigns, replacement not yet appointed

RelatediDNA Genomics bond trustee resigns, replacement not yet appointed

Trustee resignation

The decision comes after Crowdbase Ltd resigned from its role as trustee for the company’s bonds, which are listed on the corporate bond market of the CSE. iDNA Genomics made public the resignation on October 29, 2026. By the time the stock exchange took its decision, no replacement had been appointed.

Grounds for the suspension

According to the CSE, having a trustee is an ongoing obligation for the company. The lack of a replacement therefore provides grounds for stopping trading.

Duration

The suspension is due to stay in force until January 4, 2027. Trading could restart sooner if iDNA Genomics appoints a new trustee.